ph: 09 535 7218
In January 2019 new pathways were published for Skin and Soft Tissue Abscess in Adults, Mastitis and Breast Abscess and Bartholin’s Cyst or Abscess. Communications were sent via Medinz and the POAC blog – click here to sign up Following review by the regional Antimi...
Read more and comment

Hepatitis C Treatment - Update to pathway and claiming process

The Chronic Hepatitis C pathway has been updated for the newly funded direct acting antiviral (DAA) medication, Maviret™. Maviret™ is the recommended treatment in primary care for a majority of patients with Hepatitis C who do not have cirrhosis: Cure rate of 99%...
Read more and comment

Primary Care communications for new abscess management pathways

Auckland Regional HealthPathways has developed three new pathways for abscess management: Skin and soft tissue abscess in adultsBartholin's cyst or abscess Mastitis and breast abscess These best practice regionally agreed pathways have been developed with both primary a...
Read more and comment

The process for hospital referrals under POAC:

When a patient attends Urgent Care with a hospital discharge summary stating for further POAC funded treatment, this includes the following principles: The Urgent Care clinic generates the POAC referral/case number when the patient attendsThe initial consult and all treatmen...
Read more and comment

POAC OVER THE HOLIDAY PERIOD

Thank you for your support over the year, we look forward to an exciting 2019.   From our team to yours, Merry Christmas and a safe and happy holiday season! POAC HOURS OVER THE HOLIDAY: The POAC coordinators are taking a well deserved break over the Christmas and ...
Read more and comment

Pelvic Ultrasound Funding

November 7, 2018

POAC funds pelvic ultrasound scans for the following conditions:

Suspected retained products of conception beyond Section 88 funded scan time period. Persistent, heavy PV bleeding lasting more than 2 weeks following miscarriage or termination of pregnancy, or more than 6 weeks post-delivery, to rule out retained products of conception. Fo...
Read more and comment

Rivaroxaban funding

September 17, 2018

Rivaroxaban not indicated or funded before POAC DVT scan

In line with the Auckland Regional HealthPathway, when there is a delay in obtaining community ultrasound for DVT, Enoxaparin continues to be the medication to be administered and funded through POAC. The issue of using rivaroxaban instead of enoxaparin for anticoagulation c...
Read more and comment

DVT Risk Stratification

June 27, 2018
A reminder that the first action for suspected DVT is completion of Wells Score. ONLY if <2 is a d-dimer required.  If score is 2 or more then proceed directly to request for ultrasound. Awaiting d-dimer delays the ultrasound request and this may not be necessary For...
Read more and comment

Antibiotics in Acute Sore Throat or Tonsilitis

Background In patients at low risk of rheumatic fever, antibiotics should only be prescribed if the patient is severely unwell. ≥ 70% of sore throats will be viral and do not need antibiotic treatment. For risk stratification and management of sore throat see sore thr...
Read more and comment

ECG funding under POAC

April 16, 2018
The following principles apply when considering ECG funding under POAC CHEST PAIN Patients who present with current pain and high suspicion of ACS - admit as per regional acute chest pain pathway. Any management awaiting ambulance transfer is standard care and POAC...
Read more and comment
Load more
Loading...
Load more
Loading...
 

This product has been added to your cart

CHECKOUT